1. ScholarBank@NUS

NG KA-YUN, LAWRENCE

rp09515

Collaboration Map View Statistics Email Alert RSS Feed

Profile

Full Name
NG KA-YUN, LAWRENCE
(not current staff)
Variants
Ng, K.-Y.
Ng, K.Y.
Ng, K.
Ng, K.-y.
 
Main Affiliation
 
Faculty
 
Email
phalnky@nus.edu.sg
 

Publications

Results 1-5 of 5 (Search time: 0.008 seconds).

Issue DateTitleAuthor(s)
12006Topotecan is a substrate for multidrug resistance associated protein 4Tian, Q. ; Zhang, J.; Chan, S.Y. ; Chan, E.; Ho, P.C.-L. ; Ng, K.-Y. ; Zhu, S.-F. ; Tan, T.M.C. ; Duan, W. ; Yang, H.-Y.; Huang, M.; Zhu, Y.-Z. ; Bian, J.-S. ; Yu, Q.; Nie, Y.-Q.; Li, Q.; Wei, H.
2Dec-2008The impact of aqueous solubility and dose on the pharmacokinetic profiles of resveratrol (Pharmaceutical Research DOI: 10.1007/s11095-008-9677-1)Das, S.; Lin, H.-S. ; Ho, P.C. ; Ng, K.-Y. 
3May-2006Pharmacokinetic mechanisms for reduced toxicity of irinotecan by coadministered thalidomideYang, X.-X.; Hu, Z.-P.; Chan, S.Y. ; Duan, W.; Ho, P.C.-L. ; Boelsterli, U.A.; Ng, K.-Y. ; Chan, E. ; Bian, J.-S.; Chen, Y.-Z. ; Huang, M.; Zhou, S.-F. 
42006Pharmacokinetic mechanisms for reduced toxicity of irinotecan by coadministered thalidomideYang, X.-X.; Hu, Z.-P.; Chan, S.Y. ; Ho, P.C.-L. ; Boelsterli, U.A. ; Ng, K.-Y. ; Chan, E.; Chen, Y.-Z. ; Zhou, S.-F. ; Duan, W. ; Bian, J.-S. ; Huang, M.
52006Pharmacokinetic mechanisms for reduced toxicity of irinotecan by coadministered thalidomideYang, X.-X.; Hu, Z.-P.; Chan, S.Y. ; Ho, P.C.-L. ; Boelsterli, U.A. ; Ng, K.-Y. ; Chan, E.; Chen, Y.-Z. ; Zhou, S.-F. ; Duan, W. ; Bian, J.-S. ; Huang, M.